TrademarkDir
DCE PLATFORM
DEAD

Serial Number

77907107

Owner

Concert Pharmaceuticals, Inc.

Attorney

Patrick J. Concannon

First Use Date

Apr 1, 2012

Filing Date

Jan 7, 2010

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

DCE PLATFORM Trademark

Serial Number: 77907107 • Registration: 4206340

DCE PLATFORM is a trademark filed by Concert Pharmaceuticals, Inc. on January 7, 2010. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Concert Pharmaceuticals, Inc. (21 trademarks)

65 Hayden Avenue, Suite 3000N
Lexington, MA 02421

Entity Type: 03

Trademark Details

Filing Date

January 7, 2010

Registration Date

September 11, 2012

First Use Anywhere

April 1, 2012

First Use in Commerce

April 1, 2012

Published for Opposition

March 22, 2011

Cancellation Date

March 24, 2023

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Mar 24, 2023 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sep 11, 2021 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sep 20, 2018 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 20, 2018 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 20, 2018 APRE
TEAS SECTION 8 & 15 RECEIVED
Sep 11, 2018 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 11, 2017 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 12, 2015 TCCA
REGISTERED-PRINCIPAL REGISTER
Sep 11, 2012 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Aug 7, 2012 SUNA
LAW OFFICE REGISTRATION REVIEW COMPLETED
Aug 6, 2012 REGV
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 6, 2012 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 12, 2012 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 12, 2012 AITU
USE AMENDMENT FILED
May 17, 2012 IUAF
TEAS STATEMENT OF USE RECEIVED
May 17, 2012 EISU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 17, 2012 TCCA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 18, 2011 EXRA
SOU EXTENSION 1 GRANTED
Nov 16, 2011 EX1G
SOU EXTENSION 1 FILED
Nov 16, 2011 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 16, 2011 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 17, 2011 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 22, 2011 NPUB
PUBLISHED FOR OPPOSITION
Mar 22, 2011 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 16, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 15, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 25, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 25, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 27, 2010 GNRN
NON-FINAL ACTION E-MAILED
Jul 27, 2010 GNRT
NON-FINAL ACTION WRITTEN
Jul 27, 2010 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 9, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 9, 2010 CRFA
ASSIGNED TO LIE
Jul 6, 2010 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 16, 2010 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 30, 2010 GNRN
NON-FINAL ACTION E-MAILED
Mar 30, 2010 GNRT
NON-FINAL ACTION WRITTEN
Mar 30, 2010 CNRT
ASSIGNED TO EXAMINER
Mar 30, 2010 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2010 NWOS
NEW APPLICATION ENTERED
Jan 11, 2010 NWAP

Related Trademarks

More from this Owner

PRODUCT INNOVATION. PATIENT IMPACT.

PRODUCT INNOVATION. PATIENT IMPACT.

CONCERT PHARMACEUTICALS INC.

CONCERT PHARMACEUTICALS INC.

CONCERT PHARMACEUTICALS INC. logo

CONCERT PHARMACEUTICALS INC.

LEQSELVI

LEQSELVI

LEQSELVI

LEQSELVI

RENZYNCE

RENZYNCE